Methenolone mass spectrum

The risk of hepatotoxicity and death associated with CPA treatment is reportedly the reason that CPA has not been approved by the FDA for use in the United States. [50] Patients being treated with high-dose CPA should be closely monitored with liver function tests . [51] The risk is dose-dependent, and the low doses of CPA used in birth control pills (2 mg) have been said to represent a non-significant risk. [52] However, a German woman who had been taking Diane-35 (containing 2 mg/day CPA) for contraception for 14 years died of liver cancer, and this led to a safety review by drug regulators and the eventual restriction of CPA throughout Europe for the indication of acne treatment in women. [46]

Resistance to ketoconazole has been observed in a number of clinical fungal isolates, including Candida albicans . Experimentally, resistance usually arises as a result of mutations in the sterol biosynthesis pathway. Defects in the sterol 5-6 desaturase enzyme reduce the toxic effects of azole inhibition of the 14-alpha demethylation step. Multidrug-resistance (MDR) genes can also play a role in reducing cellular levels of the drug. As azole antifungals all act at the same point in the sterol pathway, resistant isolates are normally cross-resistant to all members of the azole family. [36] [37]

Masteron is a highly androgenic injectable steroid that is derived from DHT (dihydrotestosterone). DHT does not aromatize to estrogen (and in fact may combat estrogenic sides), and as a result, there was no noted water retention during administration nor gynocomastia. Masteron is almost exclusively used during the last 4-5 weeks before a bodybuilding show at a dose of 100-mg every second day. Additionally, according to available literature, Masteron is not much of a mass drug, and it's always used for cutting, from what I've seen reported. Masteron has a receptor binding ability above that of testosterone, due to it's being DHT-derived, which should impart lypolytic (fat-burning) effects above that of testosterone, and also give it a nice strength building component.

Nandrolone decanoate in the form of the Organon product, Deca-Durabolin, has been around for over 30 years. It has anabolic, androgenic, progestogenic and erythropoietic activity. The steroid maintains the anabolic activity of testosterone but the androgenic action is markedly diminished. The anabolic/androgenic quotient after 2 weeks of treatment has been shown to be 12 times that obtained with testosterone decanoate. Nandrolone decanoate has been shown to influence calcium metabolism positively and to increase bone mass in osteoporosis. Androgenic effects are relatively uncommon at the recommended therapeutic dosages.

Methenolone mass spectrum

methenolone mass spectrum

Nandrolone decanoate in the form of the Organon product, Deca-Durabolin, has been around for over 30 years. It has anabolic, androgenic, progestogenic and erythropoietic activity. The steroid maintains the anabolic activity of testosterone but the androgenic action is markedly diminished. The anabolic/androgenic quotient after 2 weeks of treatment has been shown to be 12 times that obtained with testosterone decanoate. Nandrolone decanoate has been shown to influence calcium metabolism positively and to increase bone mass in osteoporosis. Androgenic effects are relatively uncommon at the recommended therapeutic dosages.

Media:

methenolone mass spectrum

http://buy-steroids.org